(Q47727205)

5 February 2018

title

The process of metastasisation for breast cancer (English)

1 reference

5 February 2018

author name string

Engel J

1

1 reference

5 February 2018

Eckel R

2

1 reference

5 February 2018

Kerr J

3

1 reference

5 February 2018

Schmidt M

4

1 reference

5 February 2018

Fürstenberger G

5

1 reference

5 February 2018

Richter R

6

1 reference

5 February 2018

Sauer H

7

1 reference

5 February 2018

Senn HJ

8

1 reference

5 February 2018

Hölzel D

9

1 reference

5 February 2018

publication date

1 August 2003

1 reference

5 February 2018

European Journal of Cancer

published in

1 reference

5 February 2018

volume

39

1 reference

5 February 2018

issue

12

1 reference

5 February 2018

page(s)

1794-1806

1 reference

5 February 2018

Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Stopping metastases at their source

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Adequate locoregional treatment for early breast cancer may prevent secondary dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Local failure is responsible for the decrease in survival for patients with breast cancer treated with conservative surgery and postoperative radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Prognostic factors for survival after breast conserving therapy for stage I and II breast cancer. The role of local recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Local Recurrences and Distant Metastases After Conservative Breast Cancer Treatments: Partly Independent Events

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Proposal for a new model of breast cancer metastatic development

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Dormancy of mammary carcinoma after mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Breast cancer: a systemic or local disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

The link between local recurrence and distant metastases in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Cancer survival corrected for heterogeneity in patient withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Predicting the survival of patients with breast carcinoma using tumor size

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Survival and pattern of failure following locoregional recurrence of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Prognostic factors associated with survival after breast cancer recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Lead time in breast cancer detection and implications for periodicity of screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Age-dependent growth rate of primary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

The growth law of primary breast cancer as inferred from mammography screening trials data

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Beyond randomized controlled trials: organized mammographic screening substantially reduces breast carcinoma mortality

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Is the three year breast screening interval too long? Occurrence of interval cancers in NHS breast screening programme's north western region

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

[A model for primary and secondary metastasis in breast cancer and the clinical consequences]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Prognostic factors in recurrent breast cancer: relationships to site of recurrence, disease-free interval, female sex steroid receptors, ploidy and histological malignancy grading

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Survival after first recurrence of breast cancer. The Miami experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

The relationship between microscopic margins of resection and the risk of local recurrence in patients with breast cancer treated with breast-conserving surgery and radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Local recurrence after breast-conserving surgery and radiotherapy. Frequency, time course, and prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

The impact of tumor size and histology on local control after breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Endocrine and paracrine hormones in the promotion, progression and recurrence of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Histological determinants for different types of local recurrence after breast-conserving therapy of invasive breast cancer. Dutch Study Group on local Recurrence after Breast Conservation (BORST)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Locoregional recurrence of breast cancer following mastectomy: always a fatal event? Results of univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Differences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Breast recurrence following conservative surgery and radiation: patterns of failure, prognosis, and pathologic findings from mastectomy specimens with implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

The importance of locoregional control in the treatment of breast cancer and its impact on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Prognosis following local recurrence in the conservatively treated breast cancer patient

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Survival following locoregional recurrence of breast cancer: univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Prognosis following local or regional recurrence after conservative surgery and radiotherapy for early stage breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Local and distant recurrence after conservative management of "very low-risk" breast cancer are dependent events: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Radiotherapy and chemotherapy in high-risk breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Benefits of post-mastectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Long-term follow-up of axillary node-positive breast cancer patients receiving adjuvant systemic therapy alone: Patterns of recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

The role of regional nodal irradiation in the management of patients with early-stage breast cancer treated with breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Benefits of post-mastectomy radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Complete axillary lymph node dissection for stage I-II carcinoma of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

A mathematical model of axillary lymph node involvement based on 1446 complete axillary dissections in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Axillary dissection over the years: where to from here?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Tamoxifen and breast conservation: do we still need radiotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Intensive Diagnostic Follow-up After Treatment of Primary Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Predicting the rate and extent of locoregional failure after breast conservation therapy for early breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Influence of delay on survival in patients with breast cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Effect on survival of delays in referral of patients with breast-cancer symptoms: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Significance of ipsilateral breast tumour recurrence after lumpectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Monoclonal antibody therapy for resected Dukes' C colorectal cancer: seven-year outcome of a multicenter randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Radiotherapy, chemotherapy, and tamoxifen as adjuncts to surgery in early breast cancer: a summary of three randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

[Disseminated tumor cells: diagnosis, prognostic relevance, phenotyping and therapeutic strategies]

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

Cochrane review on screening for breast cancer with mammography.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2803%2900422-2

7 January 2021

10.1016/S0959-8049(03)00422-2

Identifiers

DOI

1 reference

5 February 2018

release_jb3a2q3etnbxlozx52cr6u3i7q

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jb3a2q3etnbxlozx52cr6u3i7q

24 November 2022

mapped directly with Wikidata item

1 reference

5 February 2018